Zero Life Sciences News Today

TORONTO, ON / ACCESSWIRE / May 23, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer

MGT Capital Investments is expected to report for 4Q. NantHealth Inc is expected to report $-0.20 for 4Q. Oncotelic Therapeutics Inc is expected to report for 4Q. Regional Health... -April 11, 2024 at 06:23 am EDT - MarketScreener

StageZero Life Sciences Provides an Update on Application for Management ...

Stagezero Life Sciences (TSE:SZLS) has released an update. StageZero Life Sciences, a healthcare company specializing in early cancer detection, ha...

LONDON-When Margot Robbie hosted a pool party at the Barbie Dreamhouse in last years hit film, she was thousands of miles away from sunny Malibu, on a soundstage in a commuter town about an hour... -April 04, 2024 at 06:15 am EDT - MarketScreener

Stagezero Life Sciences (TSE:SZLS) has released an update. StageZero Life Sciences has announced a delay in filing its 2023 year-end and fourth-qua...

Accord Financial is expected to report for 3Q. American Eagle Outfitters is expected to report $0.48 for 3Q. Analog Devices is expected to report $1.18 for 4Q. Axcella Health Inc is... -November 21, 2023 at 06:07 am EST - MarketScreener

StageZero Life Sciences Partners with My One Medical Source and 1,000+ ...

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Free Report) saw a large increase in short interest in October. As of October 31st, there was short interest totalling 7,400 shares, an increase of 208.3% from the October 15th total of 2,400 shares. Based on an average daily volume of 2,200 shares, the short-interest ratio is presently […]

StageZero Life Sciences Clinical Business Introduces Fourth Pillar ...